Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PROTAC TTK degrader-1, a potent threonine tyrosine kinase (TTK) PROTAC degrader, demonstrates DC50 values of 1.7 nM in COLO-205 cells and 5.8 nM in HCT-116 cells, indicating effective target degradation. Furthermore, it shows anticancer efficacy in a xenograft mouse model with COLO-205 human colorectal cancer cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | PROTAC TTK degrader-1, a potent threonine tyrosine kinase (TTK) PROTAC degrader, demonstrates DC50 values of 1.7 nM in COLO-205 cells and 5.8 nM in HCT-116 cells, indicating effective target degradation. Furthermore, it shows anticancer efficacy in a xenograft mouse model with COLO-205 human colorectal cancer cells [1]. |
In vitro | Compound 8e, a PROTAC TTK degrader-1, demonstrates antiproliferative activity against cancer cells at concentrations ranging from 0 to 10 μM over a 96-hour period [1]. |
In vivo | PROTAC TTK degrader-1 administered intraperitoneally (IP) at a single dose of 10 mg/kg exhibits satisfactory pharmacokinetic profiles [1]. When administered IP at doses of 10 or 20 mg/kg once daily over a 16-day period, PROTAC TTK degrader-1 substantially decreases TTK protein levels and demonstrates significant tumor growth inhibition [1]. |
Molecular Weight | 855.98 |
Formula | C47H53N9O7 |
CAS No. | 2953426-43-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PROTAC TTK degrader-1 2953426-43-0 PROTAC PROTACs inhibitor inhibit